Skip to content

Intervention Study on Medication Reconciliation Among Pharmacists in Two Tertiary Hospitals in Nigeria

Intervention Study on Medication Reconciliation Among Pharmacists in Two Tertiary Hospitals in Nigeria

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03182972
Enrollment
1000
Registered
2017-06-09
Start date
2016-08-02
Completion date
2019-04-30
Last updated
2022-11-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Intervention Study

Keywords

intervention study, medication reconciliation, pharmacists, Nigeria, Diabetes, Hypertension

Brief summary

This study will assess the current practice of medication reconciliation among pharmacists in the selected institutions with a view to making an intervention to address gaps discovered

Detailed description

Background information garnering will be done among the pharmacists in the two selected hospitals to collect data on current practice of medication reconciliation. Focus group discussion will be done in the intervention group so as to identify peculiarities of their practice and to provide the best approach to carrying out the intervention. Diabetes and hypertensive patients in medical outpatient clinic will be interviewed in order to assess current practice of medication reconciliation. Intervention will be channeled towards addressing gaps discovered. University College Hospital, Ibadan, Oyo State will be the intervention group, while University of Ilorin Teaching Hospital, Kwara State will be the control group. The effect of the intervention will be measured over time to ensure that medication reconciliation is implemented in the selected institutions.

Interventions

OTHERMedication reconciliation

Pre-post intervention

Sponsors

University of Ibadan
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
DOUBLE (Subject, Caregiver)

Masking description

Both the patients and the pharmacists recruited for the study will not be informed whether they are in the control or intervention group

Intervention model description

University College Hospital, Ibadan will serve as the intervention group while University of Ilorin Teaching Hospital, Ilorin will serve as the control group.

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Participant has diabetes and/or hypertension * Registered pharmacists in the selected institutions

Exclusion criteria

* Participants that are neither diabetic nor hypertensive * Unregistered pharmacists in the selected institutions

Design outcomes

Primary

MeasureTime frameDescription
Medication reconciliation: Percentage unreconciled medications3 monthsPercentage unreconciled medications

Countries

Nigeria

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026